These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 20837761)
21. Synthesis and preliminary antibacterial evaluation of Linezolid-like 1,2,4-oxadiazole derivatives. Palumbo Piccionello A; Musumeci R; Cocuzza C; Fortuna CG; Guarcello A; Pierro P; Pace A Eur J Med Chem; 2012 Apr; 50():441-8. PubMed ID: 22365410 [TBL] [Abstract][Full Text] [Related]
22. Anti-anaerobic activity of AZD2563, a new oxazolidinone, compared with eight other agents. Ednie LM; Jacobs MR; Appelbaum PC J Antimicrob Chemother; 2002 Jul; 50(1):101-5. PubMed ID: 12096013 [TBL] [Abstract][Full Text] [Related]
23. Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox(R) antimicrobial potency study in Latin America (LA-ZAPS). Ballow CH; Biedenbach DJ; Rossi F; Jones RN; Braz J Infect Dis; 2002 Jun; 6(3):100-9. PubMed ID: 12144745 [TBL] [Abstract][Full Text] [Related]
24. Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center. Smith PF; Booker BM; Ogundele AB; Kelchin P Diagn Microbiol Infect Dis; 2005 Jul; 52(3):255-9. PubMed ID: 15935606 [TBL] [Abstract][Full Text] [Related]
25. [In vitro activity of linezolid and dalbavancin against vancomycin-resistant enterococci]. Aktaş G; Bozdoğan B; Derbentli S Mikrobiyol Bul; 2012 Jul; 46(3):359-65. PubMed ID: 22951648 [TBL] [Abstract][Full Text] [Related]
26. In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones. Jones RN; Johnson DM; Erwin ME Antimicrob Agents Chemother; 1996 Mar; 40(3):720-6. PubMed ID: 8851600 [TBL] [Abstract][Full Text] [Related]
27. Linezolid activity compared to those of selected macrolides and other agents against aerobic and anaerobic pathogens isolated from soft tissue bite infections in humans. Goldstein EJ; Citron DM; Merriam CV Antimicrob Agents Chemother; 1999 Jun; 43(6):1469-74. PubMed ID: 10348773 [TBL] [Abstract][Full Text] [Related]
28. Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998-2000. Mutnick AH; Biedenbach DJ; Turnidge JD; Jones RN Diagn Microbiol Infect Dis; 2002 May; 43(1):65-73. PubMed ID: 12052631 [TBL] [Abstract][Full Text] [Related]
29. In vitro activity of tedizolid and comparator agents against clinical Gram-positive isolates recovered from patients with cancer. Rolston KVI; Reitzel R; Vargas-Cruz N; Shelburne SA; Raad II; Prince RA Diagn Microbiol Infect Dis; 2018 Aug; 91(4):351-353. PubMed ID: 29661529 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and antibacterial activity of 5-substituted oxazolidinones. Phillips OA; Udo EE; Ali AA; Al-Hassawi N Bioorg Med Chem; 2003 Jan; 11(1):35-41. PubMed ID: 12467705 [TBL] [Abstract][Full Text] [Related]
31. Tedizolid: a new oxazolidinone antimicrobial. Kisgen JJ; Mansour H; Unger NR; Childs LM Am J Health Syst Pharm; 2014 Apr; 71(8):621-33. PubMed ID: 24688035 [TBL] [Abstract][Full Text] [Related]
32. Antimicrobial activity of linezolid against Gram-positive cocci isolated in Brazil. Sader HS; Gales AC; Jones RN Braz J Infect Dis; 2001 Aug; 5(4):171-6. PubMed ID: 11712961 [TBL] [Abstract][Full Text] [Related]
33. A facile synthesis, antibacterial activity of pulvinone and its derivatives. Xu HW; Xu C; Fan ZQ; Zhao LJ; Liu HM Bioorg Med Chem Lett; 2013 Feb; 23(3):737-9. PubMed ID: 23265890 [TBL] [Abstract][Full Text] [Related]
34. Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients. Edmiston CE; Krepel CJ; Kehl KS; Seabrook GR; Somberg LB; Almassi GH; Smith TL; Loehrl TA; Brown KR; Lewis BD; Towne JB J Antimicrob Chemother; 2005 Nov; 56(5):872-8. PubMed ID: 16186167 [TBL] [Abstract][Full Text] [Related]
35. [In vitro activity of linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus]. Pérez L; Alarcón T; Jiménez S; de Las Cuevas MC; López-Brea S Rev Esp Quimioter; 2001 Mar; 14(1):47-50. PubMed ID: 11376349 [TBL] [Abstract][Full Text] [Related]
36. A review of linezolid: the first oxazolidinone antibiotic. Stevens DL; Dotter B; Madaras-Kelly K Expert Rev Anti Infect Ther; 2004 Feb; 2(1):51-9. PubMed ID: 15482171 [TBL] [Abstract][Full Text] [Related]
37. Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora. Lode H; Von der Höh N; Ziege S; Borner K; Nord CE Scand J Infect Dis; 2001; 33(12):899-903. PubMed ID: 11868762 [TBL] [Abstract][Full Text] [Related]
39. In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients. Rolston K; Wang W; Nesher L; Coyle E; Shelburne S; Prince RA J Antibiot (Tokyo); 2014 Jul; 67(7):505-9. PubMed ID: 24824818 [TBL] [Abstract][Full Text] [Related]
40. The synthesis and biological evaluation of a novel series of antimicrobials of the oxazolidinone class. Sciotti RJ; Pliushchev M; Wiedeman PE; Balli D; Flamm R; Nilius AM; Marsh K; Stolarik D; Jolly R; Ulrich R; Djuric SW Bioorg Med Chem Lett; 2002 Aug; 12(16):2121-3. PubMed ID: 12127518 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]